Dasny to sell $369.62 million in revenue bonds for Mount Sinai School of Medicine Thursday

By Sheri Kasprzak

New York, Oct. 9 - The Dormitory Authority of the State of New York is set to price $369.615 million in series 2009 revenue bonds for the Mount Sinai School of Medicine on Thursday, according to a preliminary official statement.

The bonds (A3/A-/) will be sold on a negotiated basis with J.P. Morgan Securities Inc. and Goldman, Sachs & Co. as the senior managers. The co-managers are Barclays Capital Inc., Citigroup Global Markets Inc., Fidelity Capital Markets Services, Jackson Securities Inc., Janney Montgomery Scott LLC and Merrill Lynch & Co. Inc.

The bonds are due 2017 to 2024 with term bonds due 2029, 2034 and 2039.

Proceeds will be used to make improvements at the Mount Sinai School of Medicine, which is located in New York City.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.